BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

381 related articles for article (PubMed ID: 34167520)

  • 1. Relationship between diabetes mellitus and atrial fibrillation prevalence in the Polish population: a report from the Non-invasive Monitoring for Early Detection of Atrial Fibrillation (NOMED-AF) prospective cross-sectional observational study.
    Gumprecht J; Lip GYH; Sokal A; Średniawa B; Mitręga K; Stokwiszewski J; Wierucki Ł; Rajca A; Rutkowski M; Zdrojewski T; Grodzicki T; Kaźmierczak J; Opolski G; Kalarus Z
    Cardiovasc Diabetol; 2021 Jun; 20(1):128. PubMed ID: 34167520
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of diabetes mellitus severity, treatment regimen and glycaemic control on atrial fibrillation prevalence in the Polish population aged ≥ 65.
    Gumprecht J; Lip GYH; Sokal A; Średniawa B; Stokwiszewski J; Zdrojewski T; Rutkowski M; Grodzicki T; Kaźmierczak J; Opolski G; Kalarus Z
    Sci Rep; 2023 Oct; 13(1):17252. PubMed ID: 37828071
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of atrial fibrillation in the 65 or over Polish population. Report of cross-sectional NOMED-AF study.
    Kalarus Z; Średniawa B; Mitręga K; Wierucki Ł; Sokal A; Lip G; Bandosz P; Stokwiszewski J; Boidol J; Zieleniewicz P; Rutkowski M; Kaźmierczak J; Opolski G; Grodzicki T; Zdrojewski T
    Kardiol Pol; 2023; 81(1):14-21. PubMed ID: 36043418
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of a Home-Based Wearable Continuous ECG Monitoring Patch on Detection of Undiagnosed Atrial Fibrillation: The mSToPS Randomized Clinical Trial.
    Steinhubl SR; Waalen J; Edwards AM; Ariniello LM; Mehta RR; Ebner GS; Carter C; Baca-Motes K; Felicione E; Sarich T; Topol EJ
    JAMA; 2018 Jul; 320(2):146-155. PubMed ID: 29998336
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of Remote Heart Rhythm Sampling Using the AliveCor Heart Monitor to Screen for Atrial Fibrillation: The REHEARSE-AF Study.
    Halcox JPJ; Wareham K; Cardew A; Gilmore M; Barry JP; Phillips C; Gravenor MB
    Circulation; 2017 Nov; 136(19):1784-1794. PubMed ID: 28851729
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comprehensive Evaluation of Rhythm Monitoring Strategies in Screening for Atrial Fibrillation: Insights From Patients at Risk Monitored Long Term With an Implantable Loop Recorder.
    Diederichsen SZ; Haugan KJ; Kronborg C; Graff C; Højberg S; Køber L; Krieger D; Holst AG; Nielsen JB; Brandes A; Svendsen JH
    Circulation; 2020 May; 141(19):1510-1522. PubMed ID: 32114796
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chronic kidney disease and undiagnosed atrial fibrillation in individuals with diabetes.
    Heo NJ; Rhee SY; Waalen J; Steinhubl S
    Cardiovasc Diabetol; 2020 Sep; 19(1):157. PubMed ID: 32998739
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intermittent vs continuous electrocardiogram event recording for detection of atrial fibrillation-Compliance and ease of use in an ambulatory elderly population.
    Fredriksson T; Kemp Gudmundsdottir K; Frykman V; Friberg L; Al-Khalili F; Engdahl J; Svennberg E
    Clin Cardiol; 2020 Apr; 43(4):355-362. PubMed ID: 31917467
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diabetes mellitus as risk factor for atrial fibrillation hospitalization: Incidence and outcomes over nine years in a region of Northern Italy.
    Staszewsky L; Cortesi L; Baviera M; Tettamanti M; Marzona I; Nobili A; Fortino I; Bortolotti A; Merlino L; Disertori M; Latini R; Roncaglioni MC
    Diabetes Res Clin Pract; 2015 Sep; 109(3):476-84. PubMed ID: 26220013
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical Impact of Asymptomatic Presentation Status in Patients With Paroxysmal and Sustained Atrial Fibrillation: The Fushimi AF Registry.
    Esato M; Chun YH; An Y; Ogawa H; Wada H; Hasegawa K; Tsuji H; Abe M; Lip GYH; Akao M
    Chest; 2017 Dec; 152(6):1266-1275. PubMed ID: 28823813
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Feasibility of extended ambulatory electrocardiogram monitoring to identify silent atrial fibrillation in high-risk patients: the Screening Study for Undiagnosed Atrial Fibrillation (STUDY-AF).
    Turakhia MP; Ullal AJ; Hoang DD; Than CT; Miller JD; Friday KJ; Perez MV; Freeman JV; Wang PJ; Heidenreich PA
    Clin Cardiol; 2015 May; 38(5):285-92. PubMed ID: 25873476
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predicting Silent Atrial Fibrillation in the Elderly: A Report from the NOMED-AF Cross-Sectional Study.
    Mitrega K; Lip GYH; Sredniawa B; Sokal A; Streb W; Przyludzki K; Zdrojewski T; Wierucki L; Rutkowski M; Bandosz P; Kazmierczak J; Grodzicki T; Opolski G; Kalarus Z
    J Clin Med; 2021 May; 10(11):. PubMed ID: 34073411
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Atrial Fibrillation in Patients with Embolic Stroke of Undetermined Source during 3 Years of Prolonged Monitoring with an Implantable Loop Recorder.
    Kitsiou A; Rogalewski A; Kalyani M; Deelawar S; Tribunyan S; Greeve I; Minnerup J; Israel C; Schäbitz WR
    Thromb Haemost; 2021 Jun; 121(6):826-833. PubMed ID: 33401327
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effectiveness of atrial fibrillation identification using noninvasive long-term electrocardiographic monitoring system (NOMED-AF TECH).
    Mitręga K; Średniawa B; Sokal AYH; Lip G; Rewiuk K; Rutkowski M; Zdrojewski T; Grodzicki T; Kaźmierczak J; Opolski G; Kalarus Z; Streb W
    Pol Arch Intern Med; 2023 Aug; 133(7-8):. PubMed ID: 36861462
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of Atrial Fibrillation in a Large Population Using Wearable Devices: The Fitbit Heart Study.
    Lubitz SA; Faranesh AZ; Selvaggi C; Atlas SJ; McManus DD; Singer DE; Pagoto S; McConnell MV; Pantelopoulos A; Foulkes AS
    Circulation; 2022 Nov; 146(19):1415-1424. PubMed ID: 36148649
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management and prognosis of atrial fibrillation in diabetic patients: an EORP-AF General Pilot Registry report.
    Fumagalli S; Said SA; Laroche C; Gabbai D; Boni S; Marchionni N; Boriani G; Maggioni AP; Musialik-Lydka A; Sokal A; Petersen J; Crijns HJGM; Lip GYH;
    Eur Heart J Cardiovasc Pharmacother; 2018 Jul; 4(3):172-179. PubMed ID: 29309557
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Silent atrial fibrillation detected by home-monitoring: Cardiovascular disease and stroke prevention in patients with diabetes.
    Højager A; Tingsgaard JK; Andersen D; Søholm H; Taskiran M; Bock TG; Schoos MM
    J Diabetes Complications; 2020 Dec; 34(12):107711. PubMed ID: 32900590
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anticoagulant and antiplatelet therapy for stroke prevention in atrial fibrillation patients in the clinical practice of a single district hospital in Poland.
    Bednarski J; Cieszewska E; Strzelecki A; Filipiak KJ
    Kardiol Pol; 2013; 71(12):1260-5. PubMed ID: 23990227
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Silent atrial fibrillation: epidemiology, diagnosis, and clinical impact.
    Dilaveris PE; Kennedy HL
    Clin Cardiol; 2017 Jun; 40(6):413-418. PubMed ID: 28273368
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence of atrial fibrillation and cardiovascular risk factors in a 63-65 years old general population cohort: the Akershus Cardiac Examination (ACE) 1950 Study.
    Berge T; Lyngbakken MN; Ihle-Hansen H; Brynildsen J; Pervez MO; Aagaard EN; Vigen T; Kvisvik B; Christophersen IE; Steine K; Omland T; Smith P; Røsjø H; Tveit A
    BMJ Open; 2018 Aug; 8(7):e021704. PubMed ID: 30068617
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.